Ï㽶ÊÓƵ

Skip to main content
Joshua Leitch Bonkowsky
No Rating Available
(Learn About Our Rating System)

Joshua Leitch Bonkowsky, MD, PhD

Languages spoken: English, German

Clinical Locations

Eccles Primary Children's Outpatient Services

Salt Lake City
801-213-3599
  • Dr. Josh Bonkowsky is a professor of Pediatric Neurology (Pediatrics) and of Neurology. His undergraduate training was at Harvard Ï㽶ÊÓƵ; he obtained his MD and PhD degrees at the Ï㽶ÊÓƵ of California, San Diego, and did his Pediatrics and Neurology/Pediatric Neurology training at the Ï㽶ÊÓƵ of Utah and Boston Children's Hospital.

    Dr. Bonkowsky is engaged in both clinical and basic science studies. His clinical studies are focused on understanding the clinical features of leukodystrophies, and on the genetics of complex human neurobehavioral traits, especially language impairments. Dr. Bonkowsky's clinical research group is investigating the genetics of leukodystrophies, using both local (Utah Population Database) and national databases, to understand the genetic and medical impacts of these disorders.

    Research in the Bonkowsky laboratory investigates human neurogenetic diseases, specifically diseases of basal ganglia function and white matter diseases. His group has developed zebrafish models of human language disorders (the FOXP2 gene); transgenic lines to study basal ganglia development connectivity; and a zebrafish Parkinson's disease model. Besides the basic neurodevelopmental research, his lab is generating disease models for high-throughput drug discovery.

    On sunny afternoons, Dr. Bonkowsky enjoys trail running and learning to skate ski.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
  • Dr. Josh Bonkowsky is a professor of Pediatric Neurology (Pediatrics) and of Neurology. His undergraduate training was at Harvard Ï㽶ÊÓƵ; he obtained his MD and PhD degrees at the Ï㽶ÊÓƵ of California, San Diego, and did his Pediatrics and Neurology/Pediatric Neurology training at the Ï㽶ÊÓƵ of Utah and Boston Children's Hospital.

    Dr. Bonkowsky is engaged in both clinical and basic science studies. His clinical studies are focused on understanding the clinical features of leukodystrophies, and on the genetics of complex human neurobehavioral traits, especially language impairments. Dr. Bonkowsky's clinical research group is investigating the genetics of leukodystrophies, using both local (Utah Population Database) and national databases, to understand the genetic and medical impacts of these disorders.

    Research in the Bonkowsky laboratory investigates human neurogenetic diseases, specifically diseases of basal ganglia function and white matter diseases. His group has developed zebrafish models of human language disorders (the FOXP2 gene); transgenic lines to study basal ganglia development connectivity; and a zebrafish Parkinson's disease model. Besides the basic neurodevelopmental research, his lab is generating disease models for high-throughput drug discovery.

    On sunny afternoons, Dr. Bonkowsky enjoys trail running and learning to skate ski.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Neurobiology -Adjunct
    Neurology -Adjunct
    Academic Divisions Neurology
    Board Certification
    American Board of Pediatrics (Pediatrics)

    Education history

    Other Training Physician Executive Leadership - Ï㽶ÊÓƵ of Utah School of Business
    Pediatric Neurology - Ï㽶ÊÓƵ of Utah School of Medicine Fellow
    Fellowship Pediatric Neurology - Boston Children's Medical School Fellow
    Pediatrics - Ï㽶ÊÓƵ of Utah School of Medicine Resident
    Internship Pediatrics - Ï㽶ÊÓƵ of Utah School of Medicine Intern
    Medicine, Biomedical Sciences - Ï㽶ÊÓƵ of California - San Diego School of Medicine M.D., Ph.D.
    Fellowship Institute of Molecular Pathology Fellow
    Biochemistry - Harvard College B.A.

    Selected Publications

    Journal Article

    1. Swartwood S, Wilkes J, Bonkowsky JL, Trandafir CC (2021). Celiac Disease in Children: An Association With Drug-Resistant Epilepsy. Pediatr Neurol, 120, 12-17. ()
  • Clinical Trials